DarshanTalks Podcast
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
DarshanTalks Podcast
3 Hidden Dangers of Telehealth Marketing
In this episode, we discuss how drug and device manufacturers may seem to collaborate with telemedicine companies to market products and ensure patient needs are met conveniently. However, there are three major concerns:
1. Ignoring Pharma Laws: Telehealth companies might not adhere to pharma marketing laws and could act as agents for pharma due to developed relationships. This has drawn scrutiny from Congress, FDA, and FTC, raising concerns about potential non-compliance.
2. Inappropriate Product Sales: There are significant concerns about how telehealth and marketing companies are identifying patients. Inappropriate sales to patients who don't need the products have led to Department of Justice inquiries.
3. Signing Unnecessary prescriptions: Some telehealth companies use doctors to sign off on prescriptions for patients who may not need them, often influenced by kickbacks. This practice is highly problematic and may deter pharma companies from associations unless proper controls are in place.
For assistance with advertising compliance, reach out to us!
